Cite
HARVARD Citation
Bakerly, N. et al. (2019). Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups. Respiratory medicine. pp. 58-65. [Online].